The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer/Experiment 1/Signature 1
From BugSigDB
Reviewed Marked as Reviewed by Folakunmi on 2024-4-9
Source: Fig. 3A, Supp. Table S6
Description: Differential abundance between responders and non-responders to Anti–PD-1/PD-L1 Immunotherapy in all 74 patients with Gastrointestinal Cancer
Abundance in Group 1: increased abundance in Responders to anti–PD-1/PD-L1 immunotherapy
Revision editor(s): Hamza, Scholastica
